Clear cell carcinoma is defined by ARID1A, PIK3CA, and TERT promoter mutations, and endometrioid carcinoma is defined by PTEN and PIK3CA mutations. This evidence concerns the gene PIK3CA and endometrioid adenocarcinoma.